Pregnancy and Liver Disease
Educational webinar series on best practices for diagnosing, managing, and treating liver issues in pregnant women.
Jointly provided by Postgraduate Institute for Medicine and American Liver Foundation.
This activity is supported by an independent educational grant from Abbvie.
Target Audience: This activity is intended for Physicians, Registered Nurses, Nurse Practitioners engaged in the care of patients with Liver Disease
Learning Objectives: After completing this activity, the participant should be better able to:
- Discuss how liver transplantation can affect pregnancy
- Recognize the importance of viral hepatitis and their effects on pregnancy
- List some pregnancy-associated liver diseases and their treatments
Session 1: June 17, 2021
Session 2: June 24, 2021
TIME: 6:30 PM -8:30 PM EST
LOCATION: Virtual Program
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and American Liver Foundation. Postgraduate Institute for Medicine is jointly
accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Session 1: 2.0 CME credits
Session 2: 2.0 CME credits
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 4.0 contact hours.
Session 1: 2.0 CNE credits
Session 2: 2.0 CNE credits
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. The existence or absence of COI for everyone in a position to control educational content will be disclosed to participants prior to the start of each activity.
There is no fee for this educational activity or list fee information.